Do analysts prefer TNON or QNRX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend TNON or FEMY?

Femasys has a consensus target price of $106.67, indicating a potential upside of 3,443.74%. Given Femasys' stronger consensus rating and higher possible upside, analysts plainly believe Femasys is more favorable than Tenon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Femasys 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has stronger earnings & valuation, TNON or FEMY?

Tenon Medical has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tenon Medical $3.94M 0.58 -$12.56M -$1.29 N/A Femasys $2.29M 3.97 -$18.63M -$5.40 N/A

Is TNON or FEMY more profitable?

Tenon Medical has a net margin of -270.09% compared to Femasys' net margin of -521.97%. Femasys' return on equity of -258.08% beat Tenon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Tenon Medical -270.09% -907.60% -110.17% Femasys -521.97% -258.08% -73.72%

Do analysts prefer HSCS or TNON?

HeartSciences presently has a consensus target price of $8.00, indicating a potential upside of 250.88%. Given HeartSciences' higher possible upside, equities analysts plainly believe HeartSciences is more favorable than Tenon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is HSCS or TNON more profitable?

HeartSciences has a net margin of 0.00% compared to Tenon Medical's net margin of -270.09%. HeartSciences' return on equity of -358.60% beat Tenon Medical's return on equity. Company Net Margins Return on Equity Return on Assets HeartSciences N/A -358.60% -144.82% Tenon Medical -270.09% -907.60% -110.17%

Do analysts prefer TNON or NXL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Nexalin Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend TNON or MBAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is TNON or MBAI more profitable?

Check-Cap has a net margin of 0.00% compared to Tenon Medical's net margin of -270.09%. Check-Cap's return on equity of 0.00% beat Tenon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Tenon Medical -270.09% -907.60% -110.17% Check-Cap N/A N/A N/A

Tenon Medical (TNON) Competitors

$0.19 0.00 (-0.36%)

Closing price 04:00 PM Eastern

Extended Trading

$0.19 0.00 (-0.94%)

As of 04:36 PM Eastern

Compare

TNON vs. QNRX, FEMY, HSCS, NXL, and MBAI

Should you buy Tenon Medical stock or one of its competitors? MarketBeat compares Tenon Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tenon Medical include Quoin Pharmaceuticals (QNRX), Femasys (FEMY), HeartSciences (HSCS), Nexalin Technology (NXL), and Check-Cap (MBAI).

How does Tenon Medical compare to Quoin Pharmaceuticals?

Tenon Medical (NASDAQ:TNON) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, Quoin Pharmaceuticals had 1 more articles in the media than Tenon Medical. MarketBeat recorded 1 mentions for Quoin Pharmaceuticals and 0 mentions for Tenon Medical. Tenon Medical's average media sentiment score of 0.00 equaled Quoin Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Tenon Medical	Neutral
Quoin Pharmaceuticals	Neutral

22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. 17.7% of Tenon Medical shares are held by insiders. Comparatively, 11.2% of Quoin Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Tenon Medical has higher revenue and earnings than Quoin Pharmaceuticals. Tenon Medical is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.94M	0.58	-$12.56M	-$1.29	N/A
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A

Tenon Medical has a beta of 1.39, indicating that its stock price is 39% more volatile than the broader market. Comparatively, Quoin Pharmaceuticals has a beta of 1.5, indicating that its stock price is 50% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Quoin Pharmaceuticals has a net margin of 0.00% compared to Tenon Medical's net margin of -270.09%. Quoin Pharmaceuticals' return on equity of -489.85% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-270.09%	-907.60%	-110.17%
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%

Summary

Tenon Medical beats Quoin Pharmaceuticals on 6 of the 11 factors compared between the two stocks.

How does Tenon Medical compare to Femasys?

Tenon Medical (NASDAQ:TNON) and Femasys (NASDAQ:FEMY) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 65.3% of Femasys shares are held by institutional investors. 17.7% of Tenon Medical shares are held by insiders. Comparatively, 7.8% of Femasys shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Femasys has a consensus target price of $106.67, indicating a potential upside of 3,443.74%. Given Femasys' stronger consensus rating and higher possible upside, analysts plainly believe Femasys is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Tenon Medical has a net margin of -270.09% compared to Femasys' net margin of -521.97%. Femasys' return on equity of -258.08% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-270.09%	-907.60%	-110.17%
Femasys	-521.97%	-258.08%	-73.72%

Tenon Medical has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market. Comparatively, Femasys has a beta of -2.08, suggesting that its stock price is 308% less volatile than the broader market.

In the previous week, Tenon Medical's average media sentiment score of 0.00 equaled Femasys'average media sentiment score.

Company	Overall Sentiment
Tenon Medical	Neutral
Femasys	Neutral

Tenon Medical has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.94M	0.58	-$12.56M	-$1.29	N/A
Femasys	$2.29M	3.97	-$18.63M	-$5.40	N/A

Summary

Tenon Medical and Femasys tied by winning 7 of the 14 factors compared between the two stocks.

How does Tenon Medical compare to HeartSciences?

HeartSciences (NASDAQ:HSCS) and Tenon Medical (NASDAQ:TNON) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

HeartSciences presently has a consensus target price of $8.00, indicating a potential upside of 250.88%. Given HeartSciences' higher possible upside, equities analysts plainly believe HeartSciences is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

HeartSciences has a net margin of 0.00% compared to Tenon Medical's net margin of -270.09%. HeartSciences' return on equity of -358.60% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-358.60%	-144.82%
Tenon Medical	-270.09%	-907.60%	-110.17%

In the previous week, HeartSciences had 11 more articles in the media than Tenon Medical. MarketBeat recorded 11 mentions for HeartSciences and 0 mentions for Tenon Medical. HeartSciences' average media sentiment score of 0.20 beat Tenon Medical's score of 0.00 indicating that HeartSciences is being referred to more favorably in the media.

Company	Overall Sentiment
HeartSciences	Neutral
Tenon Medical	Neutral

17.2% of HeartSciences shares are owned by institutional investors. Comparatively, 22.7% of Tenon Medical shares are owned by institutional investors. 4.9% of HeartSciences shares are owned by insiders. Comparatively, 17.7% of Tenon Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

HeartSciences has higher earnings, but lower revenue than Tenon Medical. HeartSciences is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A
Tenon Medical	$3.94M	0.58	-$12.56M	-$1.29	N/A

HeartSciences has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.39, meaning that its share price is 39% more volatile than the broader market.

Summary

HeartSciences beats Tenon Medical on 7 of the 13 factors compared between the two stocks.

How does Tenon Medical compare to Nexalin Technology?

Tenon Medical (NASDAQ:TNON) and Nexalin Technology (NASDAQ:NXL) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are held by institutional investors. 17.7% of Tenon Medical shares are held by insiders. Comparatively, 16.9% of Nexalin Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Nexalin Technology has lower revenue, but higher earnings than Tenon Medical. Nexalin Technology is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.94M	0.58	-$12.56M	-$1.29	N/A
Nexalin Technology	$300K	24.96	-$8.22M	-$0.47	N/A

Tenon Medical has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market. Comparatively, Nexalin Technology has a beta of 4, suggesting that its share price is 300% more volatile than the broader market.

Tenon Medical has a net margin of -270.09% compared to Nexalin Technology's net margin of -3,018.12%. Nexalin Technology's return on equity of -191.88% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-270.09%	-907.60%	-110.17%
Nexalin Technology	-3,018.12%	-191.88%	-166.43%

In the previous week, Nexalin Technology had 1 more articles in the media than Tenon Medical. MarketBeat recorded 1 mentions for Nexalin Technology and 0 mentions for Tenon Medical. Nexalin Technology's average media sentiment score of 1.08 beat Tenon Medical's score of 0.00 indicating that Nexalin Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
Tenon Medical	Neutral
Nexalin Technology	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Tenon Medical beats Nexalin Technology on 8 of the 15 factors compared between the two stocks.

How does Tenon Medical compare to Check-Cap?

Tenon Medical (NASDAQ:TNON) and Check-Cap (NASDAQ:MBAI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership.

Check-Cap has lower revenue, but higher earnings than Tenon Medical. Check-Cap is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.94M	0.58	-$12.56M	-$1.29	N/A
Check-Cap	N/A	N/A	$4.14M	-$2.01	N/A

In the previous week, Check-Cap had 1 more articles in the media than Tenon Medical. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for Tenon Medical. Tenon Medical's average media sentiment score of 0.00 equaled Check-Cap'saverage media sentiment score.

Company	Overall Sentiment
Tenon Medical	Neutral
Check-Cap	Neutral

Check-Cap has a net margin of 0.00% compared to Tenon Medical's net margin of -270.09%. Check-Cap's return on equity of 0.00% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-270.09%	-907.60%	-110.17%
Check-Cap	N/A	N/A	N/A

22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 17.7% of Tenon Medical shares are held by insiders. Comparatively, 0.5% of Check-Cap shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Tenon Medical has a beta of 1.39, indicating that its share price is 39% more volatile than the broader market. Comparatively, Check-Cap has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Tenon Medical beats Check-Cap on 8 of the 13 factors compared between the two stocks.

Get Tenon Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TNON vs. The Competition

Export

Metric	Tenon Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.27M	$5.65B	$6.90B	$12.88B
Dividend Yield	N/A	1.78%	2.60%	10.00%
P/E Ratio	-0.15	23.36	280.80	25.41
Price / Sales	0.58	43.76	600.03	91.19
Price / Cash	N/A	32.60	72.11	49.40
Price / Book	1.07	6.02	12.95	6.08
Net Income	-$12.56M	$151.74M	$3.49B	$348.07M
7 Day Performance	-0.57%	4.78%	3.54%	4.74%
1 Month Performance	-34.38%	-0.15%	-2.53%	-2.11%
1 Year Performance	-86.30%	8.53%	73.97%	20.71%

Tenon Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TNON Tenon Medical	1.0506 of 5 stars	$0.19 -0.4%	N/A	-86.3%	$2.27M	$3.94M	N/A	8	Gap Up
QNRX Quoin Pharmaceuticals	0.8205 of 5 stars	$4.26 +1.3%	N/A	-35.8%	$8.55M	N/A	N/A	4	Upcoming Earnings
FEMY Femasys	1.3723 of 5 stars	$2.82 -3.6%	$106.67 +3,689.2%	-81.1%	$8.50M	$2.29M	N/A	30	Upcoming Earnings
HSCS HeartSciences	2.835 of 5 stars	$2.09 -7.5%	$8.00 +282.8%	-37.0%	$8.15M	N/A	N/A	10	Gap Down
NXL Nexalin Technology	0.4925 of 5 stars	$0.37 +9.3%	N/A	-63.7%	$8.06M	$300K	N/A	3	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TNON) was last updated on 8/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tenon Medical (TNON) Competitors

TNON vs. QNRX, FEMY, HSCS, NXL, and MBAI

How does Tenon Medical compare to Quoin Pharmaceuticals?

Summary

How does Tenon Medical compare to Femasys?

Summary

How does Tenon Medical compare to HeartSciences?

Summary

How does Tenon Medical compare to Nexalin Technology?

Summary

How does Tenon Medical compare to Check-Cap?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNON vs. The Competition

Tenon Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tenon Medical (TNON) Competitors

TNON vs. QNRX, FEMY, HSCS, NXL, and MBAI

How does Tenon Medical compare to Quoin Pharmaceuticals?

Does the media refer more to TNON or QNRX?

Do insiders & institutionals hold more shares of TNON or QNRX?

Which has higher earnings and valuation, TNON or QNRX?

Which has more risk and volatility, TNON or QNRX?

Do analysts prefer TNON or QNRX?

Is TNON or QNRX more profitable?

Summary

How does Tenon Medical compare to Femasys?

Do insiders & institutionals believe in TNON or FEMY?

Do analysts recommend TNON or FEMY?

Is TNON or FEMY more profitable?

Which has more risk & volatility, TNON or FEMY?

Does the media refer more to TNON or FEMY?

Which has stronger earnings & valuation, TNON or FEMY?

Summary

How does Tenon Medical compare to HeartSciences?

Do analysts prefer HSCS or TNON?

Is HSCS or TNON more profitable?

Does the media prefer HSCS or TNON?

Do insiders & institutionals have more ownership in HSCS or TNON?

Which has higher earnings and valuation, HSCS or TNON?

Which has more volatility and risk, HSCS or TNON?

Summary

How does Tenon Medical compare to Nexalin Technology?

Do institutionals & insiders believe in TNON or NXL?

Which has higher valuation and earnings, TNON or NXL?

Which has more risk and volatility, TNON or NXL?

Is TNON or NXL more profitable?

Does the media refer more to TNON or NXL?

Do analysts prefer TNON or NXL?

Summary

How does Tenon Medical compare to Check-Cap?

Which has stronger valuation & earnings, TNON or MBAI?

Does the media favor TNON or MBAI?

Is TNON or MBAI more profitable?

Do insiders and institutionals hold more shares of TNON or MBAI?

Which has more risk and volatility, TNON or MBAI?

Do analysts recommend TNON or MBAI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNON vs. The Competition

Tenon Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools